Search
forResearch 10 of 226
- Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC).
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →